This study highlights the overlap between PMS and metabolic-associated steatotic liver disease (MASLD), focusing on PNPLA3 variants and underscoring the need for structured metabolic monitoring. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.